BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Pharm Country

  First Patient Enrolled in Phase III Studies Using OptiNose’s Novel Breath Powered™ Device to Deliver Fluticasone Intranasally for Treatment of Nasal Polyps

  October 31, 2013

   · 

  6 min read
• Drug Development

  EntreMed, Inc. Commences Phase 2 Trial for ENMD-2076 in Ovarian Clear Cell Carcinomas

  October 31, 2013

   · 

  6 min read
• Pharm Country

  electroCore’s Clinical Trial Program Into Non Invasive Vagus Nerve Stimulation Therapy Gathers Momentum

  October 31, 2013

   · 

  1 min read
• Drug Development

  Clovis Oncology Announces First Patient Enrolled in ARIEL2 Study of Rucaparib in Ovarian Cancer

  October 31, 2013

   · 

  1 min read
• Drug Development

  Protalex, Inc. Initiates Enrollment of Final Cohort in Phase 1b Trial of PRTX-100 in Active Rheumatoid Arthritis Patients

  October 31, 2013

   · 

  1 min read
• Drug Development

  CytoDyn Submits Phase IIb Protocol for PRO 140 Clinical Trial to FDA

  October 31, 2013

   · 

  1 min read
• Biotech Beach

  Allegro Ophthalmics LLC and the Helmsley Charitable Trust to Present at Partnering for Cures

  October 31, 2013

   · 

  1 min read
• Pharm Country

  CIS Webinar Shares Critical Elements for Effective Vendor Oversight

  October 31, 2013

   · 

  2 min read
• Policy

  Bio-Matrix Scientific Group Inc.’ Regen BioPharma Retains Cook General Biotechnology for Contract Manufacturing of HemaXellerate I

  October 31, 2013

   · 

  2 min read
• Drug Development

  Immunocore Limited Initiates Phase IIa Clinical Trial for IMCgp100 in Melanoma

  October 31, 2013

   · 

  4 min read